Risk Prediction Models for Patients With Chronic Kidney Disease A Systematic Review

被引:167
作者
Tangri, Navdeep
Kitsios, Georgios D.
Inker, Lesley Ann
Griffith, John
Naimark, David M.
Walker, Simon
Rigatto, Claudio
Uhlig, Katrin
Kent, David M.
Levey, Andrew S.
机构
[1] Univ Manitoba, Winnipeg, MB, Canada
[2] Tufts Med Ctr, Boston, MA USA
[3] Univ Toronto, Sunnybrook Hosp, Toronto, ON, Canada
关键词
TYPE-2; DIABETES-MELLITUS; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR EVENTS; HIGHER ALBUMINURIA; DARBEPOETIN-ALPHA; IGA NEPHROPATHY; SCORING SYSTEM; ESTIMATED GFR; MORTALITY; PROGRESSION;
D O I
10.7326/0003-4819-158-8-201304160-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with chronic kidney disease (CKD) are at increased risk for kidney failure, cardiovascular events, and all-cause mortality. Accurate models are needed to predict the individual risk for these outcomes. Purpose: To systematically review risk prediction models for kidney failure, cardiovascular events, and death in patients with CKD. Data Sources: MEDLINE search of English-language articles published from 1966 to November 2012. Study Selection: Cohort studies that examined adults with any stage of CKD who were not receiving dialysis and had not had a transplant; had at least 1 year of follow-up; and reported on a model that predicted the risk for kidney failure, cardiovascular events, or all-cause mortality. Data Extraction: Reviewers extracted data on study design, population characteristics, modeling methods, metrics of model performance, risk of bias, and clinical usefulness. Data Synthesis: Thirteen studies describing 23 models were found. Eight studies (11 models) involved kidney failure, 5 studies (6 models) involved all-cause mortality, and 3 studies (6 models) involved cardiovascular events. Measures of estimated glomerular filtration rate or serum creatinine level were included in 10 studies (17 models), and measures of proteinuria were included in 9 studies (15 models). Only 2 studies (4 models) met the criteria for clinical usefulness, of which 1 study (3 models) presented reclassification indices with clinically useful risk categories. Limitation: A validated risk-of-bias tool and comparisons of the performance of different models in the same validation population were lacking. Conclusion: Accurate, externally validated models for predicting risk for kidney failure in patients with CKD are available and ready for clinical testing. Further development of models for cardiovascular events and all-cause mortality is needed.
引用
收藏
页码:596 / +
页数:11
相关论文
共 42 条
[1]   Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts [J].
Astor, Brad C. ;
Matsushita, Kunihiro ;
Gansevoort, Ron T. ;
van der Velde, Marije ;
Woodward, Mark ;
Levey, Andrew S. ;
de Jong, Paul E. ;
Coresh, Josef .
KIDNEY INTERNATIONAL, 2011, 79 (12) :1331-1340
[2]   Predicting the Risk for Dialysis or Death in IgA Nephropathy [J].
Berthoux, Francois ;
Mohey, Hesham ;
Laurent, Blandine ;
Mariat, Christophe ;
Afiani, Aida ;
Thibaudin, Lise .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (04) :752-761
[3]   The Framingham Heart Study's Impact on Global Risk Assessment [J].
Bitton, Asaf ;
Gaziano, Thomas .
PROGRESS IN CARDIOVASCULAR DISEASES, 2010, 53 (01) :68-78
[4]   Reporting and Methods in Clinical Prediction Research: A Systematic Review [J].
Bouwmeester, Walter ;
Zuithoff, Nicolaas P. A. ;
Mallett, Susan ;
Geerlings, Mirjam I. ;
Vergouwe, Yvonne ;
Steyerberg, Ewout W. ;
Altman, Douglas G. ;
Moons, Karel G. M. .
PLOS MEDICINE, 2012, 9 (05)
[5]   Systematic review of prognostic models in patients with acute stroke [J].
Counsell, C ;
Dennis, M .
CEREBROVASCULAR DISEASES, 2001, 12 (03) :159-170
[6]   Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation [J].
D'Agostino, RB ;
Grundy, S ;
Sullivan, LM ;
Wilson, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02) :180-187
[7]   Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD [J].
Desai, Akshay S. ;
Toto, Robert ;
Jarolim, Petr ;
Uno, Hajime ;
Eckardt, Kai-Uwe ;
Kewalramani, Reshma ;
Levey, Andrew S. ;
Lewis, Eldrin F. ;
McMurray, John J. V. ;
Parving, Hans-Henrik ;
Solomon, Scott D. ;
Pfeffer, Marc A. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 58 (05) :717-728
[8]   Chronic nephropathies: Individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model [J].
Dimitrov, BD ;
Ruggenenti, P ;
Stefanov, R ;
Perna, A ;
Remuzzi, G .
NEPHRON CLINICAL PRACTICE, 2003, 95 (02) :C47-C59
[9]   Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts [J].
Gansevoort, Ron T. ;
Matsushita, Kunihiro ;
van der Velde, Marije ;
Astor, Brad C. ;
Woodward, Mark ;
Levey, Andrew S. ;
de Jong, Paul E. ;
Coresh, Josef .
KIDNEY INTERNATIONAL, 2011, 80 (01) :93-104
[10]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305